Skip to main content
Erschienen in: Updates in Surgery 4/2019

24.09.2019 | Original Article

Accuracy of positron emission tomography and computed tomography (PET/CT) in detecting nodal metastasis according to histology of non-small cell lung cancer

verfasst von: David E. Smith, Julian Fernandez Aramburu, Alejandro Da Lozzo, Juan A. Montagne, Enrique Beveraggi, Agustin Dietrich

Erschienen in: Updates in Surgery | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Positron emission tomography and computed tomography (PET–CT) is the non-invasive gold standard method for determining the oncological stage of patient with diagnosis of lung cancer. A correct preoperative staging is significant because only patients who do not have a history of regional or distant disease are those who will benefit from a surgical treatment. However, due to the different values of the PET–CT in terms of sensitivity and specificity to evaluate the mediastinal lymph node involvement, it is often necessary to perform a surgical mediastinal sampling through a cervical video mediastinoscopy (VM). Patient’s risk factors which could modify the results of the PET scan, performing differences between non-invasive staging and the lymph node sampling due to VM are not yet clearly established in the literature. This knowledge will allow to identify in whom a surgical staging by sampling the mediastinal lymph nodes is needed. We included 234 patients with diagnosis of lung cancer who underwent a mediastinal lymph node staging by PET–CT images and histopathological results of mediastinal sampling by VM, analyzing the sensitivity and specificity of this non-invasive imaging study. We also analyzed variables that could modify the results of PET–CT, such as tumor type, location of the tumor and patient’s history. We showed that those PET–CT presented an overall sensitivity and specificity of 93.8 and 62.7%, respectively, with negative and positive predictive values of 95.05 and 57.1%, respectively. The false-positive rate was 25% (57 of 234 patients). Analyzing risk factors involved in this false-positive rate (n = 57), we found that the only statistically significant factor that could explain these results was the histology of squamous carcinoma (p < 0.03). In this group of patients, it is essential to perform a mediastinal lymph node biopsy to know the real state of lymph node involvement.
Literatur
1.
Zurück zum Zitat Cerfolio RJ, Ojha B, Bryant AS et al (2004) The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg 78(3):1017–1023 (discussion 1017–23) CrossRef Cerfolio RJ, Ojha B, Bryant AS et al (2004) The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg 78(3):1017–1023 (discussion 1017–23) CrossRef
2.
Zurück zum Zitat Liu BJ, Dong JC, Xu CQ (2009) Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers. Chin Med J (Engl) 122(15):1749–1754 Liu BJ, Dong JC, Xu CQ (2009) Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers. Chin Med J (Engl) 122(15):1749–1754
3.
Zurück zum Zitat Konishi J, Yamazaki K, Tsukamoto E (2003) Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 70(5):500–506CrossRef Konishi J, Yamazaki K, Tsukamoto E (2003) Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 70(5):500–506CrossRef
4.
Zurück zum Zitat Takamochi K, Yoshida J, Murakami K (2005) Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 47(2):235–242CrossRef Takamochi K, Yoshida J, Murakami K (2005) Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 47(2):235–242CrossRef
8.
Zurück zum Zitat Ose N, Sawabata N, Minami M et al (2012) Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-d-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer. Eur J Cardiothorac Surg 42(1):89–92. https://doi.org/10.1093/ejcts/ezr287(Epub 2012 Jan 18) CrossRefPubMed Ose N, Sawabata N, Minami M et al (2012) Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-d-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer. Eur J Cardiothorac Surg 42(1):89–92. https://​doi.​org/​10.​1093/​ejcts/​ezr287(Epub 2012 Jan 18) CrossRefPubMed
9.
Zurück zum Zitat Billè A, Okiror L, Skanjeti A et al (2013) Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma. Eur J Cardiothorac Surg 43(3):574–579. https://doi.org/10.1093/ejcts/ezs366(Epub 2012 Jun 11) CrossRefPubMed Billè A, Okiror L, Skanjeti A et al (2013) Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma. Eur J Cardiothorac Surg 43(3):574–579. https://​doi.​org/​10.​1093/​ejcts/​ezs366(Epub 2012 Jun 11) CrossRefPubMed
10.
Zurück zum Zitat Chansky K, Detterbeck FC, Nicholson AG et al (2017) The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 12(7):1109–1121CrossRef Chansky K, Detterbeck FC, Nicholson AG et al (2017) The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 12(7):1109–1121CrossRef
11.
Zurück zum Zitat Call S, Rami-Porta R, Obiols C (2012) Extended cervical mediastinoscopy. Multimed Man Cardiothorac Surg 2012:mms018PubMed Call S, Rami-Porta R, Obiols C (2012) Extended cervical mediastinoscopy. Multimed Man Cardiothorac Surg 2012:mms018PubMed
12.
Zurück zum Zitat De Leyn P, Lardinois D, Van Schil PE et al (2007) ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32(1):1–8 (Epub 2007 Apr 19) CrossRef De Leyn P, Lardinois D, Van Schil PE et al (2007) ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32(1):1–8 (Epub 2007 Apr 19) CrossRef
13.
Zurück zum Zitat Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study group. Ann Thorac Surg 60(3):615–622 (discussion 622–3) CrossRef Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study group. Ann Thorac Surg 60(3):615–622 (discussion 622–3) CrossRef
14.
Zurück zum Zitat Kim B-T, Lee KS, Shim SS et al (2006) Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT—a prospective study. Radiology 241:501–509CrossRef Kim B-T, Lee KS, Shim SS et al (2006) Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT—a prospective study. Radiology 241:501–509CrossRef
15.
Zurück zum Zitat Cerfolio RJ, Bryant AS, Ojha B, Eloubeidi M (2005) Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg 80:1207–1214CrossRef Cerfolio RJ, Bryant AS, Ojha B, Eloubeidi M (2005) Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg 80:1207–1214CrossRef
16.
Zurück zum Zitat Shim SS, Lee KS, Kim B-T et al (2005) Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236:1011–1019CrossRef Shim SS, Lee KS, Kim B-T et al (2005) Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 236:1011–1019CrossRef
18.
Zurück zum Zitat Little AG, Rusch VW, Bonner JA et al (2005) Patterns of surgical care of lung cancer patients. Ann Thorac Surg 80(6):2051–2056 (discussion 2056) CrossRef Little AG, Rusch VW, Bonner JA et al (2005) Patterns of surgical care of lung cancer patients. Ann Thorac Surg 80(6):2051–2056 (discussion 2056) CrossRef
20.
Zurück zum Zitat Konishi J, Yamazaki K, Tsukamoto E et al (2003) Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 70(5):500–506CrossRef Konishi J, Yamazaki K, Tsukamoto E et al (2003) Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 70(5):500–506CrossRef
21.
Zurück zum Zitat Roberts PF, Follette DM, von Haag D et al (2000) Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 70(4):1154–1159 (discussion 1159–60) CrossRef Roberts PF, Follette DM, von Haag D et al (2000) Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 70(4):1154–1159 (discussion 1159–60) CrossRef
Metadaten
Titel
Accuracy of positron emission tomography and computed tomography (PET/CT) in detecting nodal metastasis according to histology of non-small cell lung cancer
verfasst von
David E. Smith
Julian Fernandez Aramburu
Alejandro Da Lozzo
Juan A. Montagne
Enrique Beveraggi
Agustin Dietrich
Publikationsdatum
24.09.2019
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 4/2019
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-019-00680-x

Weitere Artikel der Ausgabe 4/2019

Updates in Surgery 4/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.